IP Library › Granted Patent US 7,994,285
Granted Patent B2
US 7,994,285 · App. 11/874,645 · Granted Aug 9, 2011

Anti-Notch3 antibodies

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,994,285
App. No.
11/874,645
Granted
Aug 9, 2011
Kind
B2
Abstract

The present invention relates to novel antibodies that bind specifically to human Notch 3 and their use in the detection and/or diagnosis of Notch 3 related diseases, such as cancer. The present invention also includes nucleic acids encoding these novel antibodies, vectors and cell lines harboring the nucleic acids, and kits comprising the antibodies for use in the detection and diagnosis.

Claims (9)

1. An isolated antibody comprising a variable light (VL) chain region comprising the amino acid sequence of SEQ ID NO: 5, wherein the antibody binds specifically to Notch3.

2. An isolated antibody comprising a variable heavy (VH) chain region comprising the amino acid sequence of SEQ ID NO: 4, wherein the antibody binds specifically to Notch3.

3. The antibody of claim 1 , further comprising a variable heavy (VH) chain region comprising the amino acid sequence of SEQ ID NO: 4.

4. An isolated antibody comprising a variable heavy (VH) chain region comprising complementarity determining regions (CDRs) of SEQ ID NO: 14, 15, and 16, wherein the antibody binds specifically to Notch3.

5. An isolated antibody comprising a variable light (VL) chain region comprising complementarity determining regions (CDRs) of SEQ ID NO: 17, 18, and 19, wherein the antibody binds specifically to Notch3.

6. The antibody of claim 4 , further comprising a variable light (VL) chain region comprising CDRs of SEQ ID NO: 17, 18, and 19.

7. The antibody of any of claims 1 - 3 , 4 - 5 , and 6 , wherein the antibody is an antibody fragment.

8. The antibody of claim 7 , wherein the antibody is a single chain Fv.

9. The antibody of any of claims 1 - 3 , 4 - 5 , and 6 , further comprising a label.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2008
From: LI, KANG; FUNG, SEK CHUNG; YAO, ZHENGBIN
To: GENENTECH INC.
Reel/Frame 020535/0604 →
Continuity (2)
Provisional Application 60852861 · Oct 19, 2006
Related Publication 20080131908A1 · Jun 5, 2008